{
  "normalized_facts": [
    {
      "raw_fact": {
        "drug_name": "escitalopram",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": "remission rate",
        "side_effects": [
          "nausea",
          "sexual dysfunction"
        ],
        "effect_size": "42% remission vs 28% placebo, NNT=7",
        "confidence_interval": "95% CI 1.2\u20132.4",
        "source_id": "WJCC",
        "section": "World Journal of Clinical Cases",
        "span": "In an 8\u2011week randomized trial (n=485) in adults with major depressive disorder, escitalopram 10\u201320 mg/day achieved higher remission (42% vs 28% placebo; NNT=7; 95% CI 1.2\u20132.4; p<0.01). Nausea and sexual dysfunction were the most frequent adverse events.",
        "confidence": 1.0,
        "treatment_line": "first",
        "patient_subgroup": null,
        "study_design": "RCT",
        "sample_size": 485,
        "duration": "8 weeks",
        "dose": "10\u201320 mg/day",
        "p_value": 0.001
      },
      "drug": {
        "text": "escitalopram",
        "concept_id": "RXNORM:316137",
        "label": "Escitalopram",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "FIRST_LINE_FOR",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": {
        "text": "remission rate",
        "concept_id": "SNOMED:277022003",
        "label": "Remission phase",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "side_effects": [
        {
          "text": "nausea",
          "concept_id": "SNOMED:422587007",
          "label": "Nausea",
          "provider": "snomed",
          "match_type": "exact",
          "score": 1.0
        },
        {
          "text": "sexual dysfunction",
          "concept_id": "SNOMED:56627002",
          "label": "Sexual dysfunction",
          "provider": "snomed",
          "match_type": "exact",
          "score": 1.0
        }
      ],
      "effect_size": "42% remission vs 28% placebo, NNT=7",
      "confidence_interval": "95% CI 1.2\u20132.4"
    },
    {
      "raw_fact": {
        "drug_name": "sertraline",
        "condition_name": "major depressive disorder",
        "relation": "PREVENTS_RELAPSE_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "World Journal of Clinical Cases",
        "span": "Continuation treatment with sertraline over 6 months reduced relapse rates compared with placebo in patients with major depressive disorder, according to a randomized withdrawal design.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "RCT",
        "sample_size": 312,
        "duration": "6 months",
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "sertraline",
        "concept_id": "RXNORM:3640",
        "label": "Sertraline",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "PREVENTS_RELAPSE_IN",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "cognitive behavioral therapy",
        "condition_name": "major depressive disorder",
        "relation": "WELL_TOLERATED_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "World Journal of Clinical Cases",
        "span": "In adolescents with major depressive disorder treated in outpatient settings, cognitive behavioral therapy was generally well tolerated with low discontinuation for adverse events.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": "adolescents",
        "study_design": "observational",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "cognitive behavioral therapy",
        "concept_id": "SNOMED:40803007",
        "label": "Cognitive behavioral therapy",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "WELL_TOLERATED_IN",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "escitalopram",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": "remission rate",
        "side_effects": [
          "nausea",
          "sexual dysfunction"
        ],
        "effect_size": "42% remission vs 28% placebo, NNT=7",
        "confidence_interval": "95% CI 1.2\u20132.4",
        "source_id": "WJCC",
        "section": "Major depressive disorder: Validated treatments and future challenges",
        "span": "In an 8\u2011week randomized trial (n=485) in adults with major depressive disorder, escitalopram 10\u201320 mg/day achieved higher remission (42% vs 28% placebo; NNT=7; 95% CI 1.2\u20132.4; p<0.01). Nausea and sexual dysfunction were the most frequent adverse events.",
        "confidence": 1.0,
        "treatment_line": "first",
        "patient_subgroup": null,
        "study_design": "RCT",
        "sample_size": 485,
        "duration": "8 weeks",
        "dose": "10\u201320 mg/day",
        "p_value": 0.001
      },
      "drug": {
        "text": "escitalopram",
        "concept_id": "RXNORM:316137",
        "label": "Escitalopram",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "FIRST_LINE_FOR",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": {
        "text": "remission rate",
        "concept_id": "SNOMED:277022003",
        "label": "Remission phase",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "side_effects": [
        {
          "text": "nausea",
          "concept_id": "SNOMED:422587007",
          "label": "Nausea",
          "provider": "snomed",
          "match_type": "exact",
          "score": 1.0
        },
        {
          "text": "sexual dysfunction",
          "concept_id": "SNOMED:56627002",
          "label": "Sexual dysfunction",
          "provider": "snomed",
          "match_type": "exact",
          "score": 1.0
        }
      ],
      "effect_size": "42% remission vs 28% placebo, NNT=7",
      "confidence_interval": "95% CI 1.2\u20132.4"
    },
    {
      "raw_fact": {
        "drug_name": "sertraline",
        "condition_name": "major depressive disorder",
        "relation": "PREVENTS_RELAPSE_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Major depressive disorder: Validated treatments and future challenges",
        "span": "Continuation treatment with sertraline over 6 months reduced relapse rates compared with placebo in patients with major depressive disorder, according to a randomized withdrawal design.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "RCT",
        "sample_size": 312,
        "duration": "6 months",
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "sertraline",
        "concept_id": "RXNORM:3640",
        "label": "Sertraline",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "PREVENTS_RELAPSE_IN",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "cognitive behavioral therapy",
        "condition_name": "major depressive disorder",
        "relation": "WELL_TOLERATED_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Major depressive disorder: Validated treatments and future challenges",
        "span": "In adolescents with major depressive disorder treated in outpatient settings, cognitive behavioral therapy was generally well tolerated with low discontinuation for adverse events.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": "adolescents",
        "study_design": "observational",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "cognitive behavioral therapy",
        "concept_id": "SNOMED:40803007",
        "label": "Cognitive behavioral therapy",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "WELL_TOLERATED_IN",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "selective serotonin reuptake inhibitors",
        "condition_name": "depression",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "abstract",
        "span": "Pharmacotherapy, especially selective serotonin reuptake inhibitors antidepressants, remains the most frequent option for treating depression during the acute phase.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "selective serotonin reuptake inhibitors",
        "concept_id": "RXNORM:372652",
        "label": "SSRIs",
        "provider": "rxnorm",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "FIRST_LINE_FOR",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "depression-focused psychotherapy",
        "condition_name": "depression",
        "relation": "MAINTENANCE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "abstract",
        "span": "Depression-focused psychotherapy is the second most common option for helping patients overcome the acute phase, maintain remission, and prevent relapses.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "depression-focused psychotherapy",
        "concept_id": "SNOMED:76168009",
        "label": "Psychotherapy",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "MAINTENANCE_FOR",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "depression-focused psychotherapy",
        "condition_name": "depression",
        "relation": "PREVENTS_RELAPSE_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "abstract",
        "span": "Depression-focused psychotherapy is the second most common option for helping patients overcome the acute phase, maintain remission, and prevent relapses.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "depression-focused psychotherapy",
        "concept_id": "SNOMED:76168009",
        "label": "Psychotherapy",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "PREVENTS_RELAPSE_IN",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "electroconvulsive therapy",
        "condition_name": "depression",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "abstract",
        "span": "Electroconvulsive therapy is the most effective somatic therapy for depression in some specific situations.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": "specific situations",
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "electroconvulsive therapy",
        "concept_id": "SNOMED:228557008",
        "label": "Electroconvulsive therapy",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "EFFECTIVE_IN_SUBGROUP",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "pharmacotherapy",
        "condition_name": "major depressive disorder",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "introduction",
        "span": "Acute-phase treatment options include pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT).",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "pharmacotherapy",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "TREATS",
        "concept_id": "CUSTOM:0001",
        "label": "TREATS",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "depression-focused psychotherapy",
        "condition_name": "major depressive disorder",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "introduction",
        "span": "Acute-phase treatment options include pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT).",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "depression-focused psychotherapy",
        "concept_id": "SNOMED:76168009",
        "label": "Psychotherapy",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "TREATS",
        "concept_id": "CUSTOM:0001",
        "label": "TREATS",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "electroconvulsive therapy",
        "condition_name": "major depressive disorder",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "introduction",
        "span": "Acute-phase treatment options include pharmacotherapy, depression-focused psychotherapy, combinations of medications and psychotherapy, and somatic therapies such as electroconvulsive therapy (ECT).",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "electroconvulsive therapy",
        "concept_id": "SNOMED:228557008",
        "label": "Electroconvulsive therapy",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "TREATS",
        "concept_id": "CUSTOM:0001",
        "label": "TREATS",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "TCAs",
        "condition_name": "major depressive disorder",
        "relation": "EQUIVALENT_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "TCAs",
        "span": "TCAs-such as amitriptyline, nortriptyline, protriptyline, imipramine, desipramine, doxepin, and trimipramine-are about as effective as other classes of antidepressants-including SSRIs, SNRIs, and MAOIs-in treating major depression.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "comparative",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "TCAs",
        "concept_id": "RXNORM:321988",
        "label": "TCAs",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "EQUIVALENT_TO",
        "concept_id": "CUSTOM:0008",
        "label": "EQUIVALENT_TO",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "TCAs",
        "condition_name": "major depressive disorder",
        "relation": "SUPERIOR_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "TCAs",
        "span": "However, some TCAs can be more effective than SSRIs when used to treat hospitalized patients. This efficacy can be explained by the superiority of TCAs over SSRIs for patients with severe major depressive disorder (MDD) symptoms who require hospitalization.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": "hospitalized patients with severe symptoms",
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "TCAs",
        "concept_id": "RXNORM:321988",
        "label": "TCAs",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "SUPERIOR_TO",
        "concept_id": "CUSTOM:0006",
        "label": "SUPERIOR_TO",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "TCAs",
        "condition_name": "major depressive disorder",
        "relation": "CONTRAINDICATED_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "TCAs",
        "span": "In most cases, TCAs should generally be reserved for situations when first-line drug treatments have failed.",
        "confidence": 0.8,
        "treatment_line": "first",
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "TCAs",
        "concept_id": "RXNORM:321988",
        "label": "TCAs",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "CONTRAINDICATED_FOR",
        "concept_id": "CUSTOM:0005",
        "label": "CONTRAINDICATED_FOR",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "fluoxetine",
        "condition_name": "depression",
        "relation": "EQUIVALENT_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SSRIs",
        "span": "In December 1987, a series of clinical studies confirmed that an SSRI called fluoxetine was as effective as TCAs for treating depression while causing fewer adverse effects.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "clinical studies",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "fluoxetine",
        "concept_id": "RXNORM:4493",
        "label": "Fluoxetine",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "EQUIVALENT_TO",
        "concept_id": "CUSTOM:0008",
        "label": "EQUIVALENT_TO",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "SSRIs",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SSRIs",
        "span": "Therefore, most guidelines currently recommend SSRIs as the first-line treatment for patients with major depression.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "SSRIs",
        "concept_id": "RXNORM:372652",
        "label": "SSRIs",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "FIRST_LINE_FOR",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "SSRIs",
        "condition_name": "depression",
        "relation": "EQUIVALENT_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SSRIs",
        "span": "In most systematic reviews and meta-analyses, SSRIs have demonstrated comparable efficacy to TCAs.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "SSRIs",
        "concept_id": "RXNORM:372652",
        "label": "SSRIs",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "EQUIVALENT_TO",
        "concept_id": "CUSTOM:0008",
        "label": "EQUIVALENT_TO",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "SSRIs",
        "condition_name": "depression",
        "relation": "WELL_TOLERATED_IN",
        "outcome": null,
        "side_effects": [
          "sexual dysfunction",
          "nausea",
          "loss of appetite",
          "irritability",
          "anxiety",
          "insomnia",
          "headaches"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SSRIs",
        "span": "Currently available SSRIs include fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, and escitalopram. They have elicited different tolerance rates and side effects-mostly sexual and digestive (nausea and loss of appetite), as well as irritability, anxiety, insomnia, and headaches. Nevertheless, SSRIs have a good tolerability profile.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "SSRIs",
        "concept_id": "RXNORM:372652",
        "label": "SSRIs",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "WELL_TOLERATED_IN",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [
        {
          "text": "sexual dysfunction",
          "concept_id": "SNOMED:56627002",
          "label": "Sexual dysfunction",
          "provider": "snomed",
          "match_type": "exact",
          "score": 1.0
        },
        {
          "text": "nausea",
          "concept_id": "SNOMED:422587007",
          "label": "Nausea",
          "provider": "snomed",
          "match_type": "exact",
          "score": 1.0
        },
        {
          "text": "loss of appetite",
          "concept_id": "SNOMED:89362005",
          "label": "Weight loss",
          "provider": "snomed",
          "match_type": "synonym",
          "score": 1.0
        },
        {
          "text": "irritability",
          "concept_id": "SNOMED:24199005",
          "label": "Feeling agitated",
          "provider": "snomed",
          "match_type": "synonym",
          "score": 1.0
        },
        {
          "text": "anxiety",
          "concept_id": "SNOMED:48694002",
          "label": "Anxiety",
          "provider": "snomed",
          "match_type": "exact",
          "score": 1.0
        },
        {
          "text": "insomnia",
          "concept_id": "SNOMED:193462001",
          "label": "Insomnia",
          "provider": "snomed",
          "match_type": "exact",
          "score": 1.0
        },
        {
          "text": "headaches",
          "concept_id": "SNOMED:25064002",
          "label": "Headache",
          "provider": "snomed",
          "match_type": "fuzzy",
          "score": 0.9411764705882353
        }
      ],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "venlafaxine",
        "condition_name": "depression",
        "relation": "EQUIVALENT_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Norepinephrine reuptake inhibitors",
        "span": "Also, venlafaxine's efficacy is comparable to that of TCAs.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "individual studies",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "venlafaxine",
        "concept_id": "RXNORM:39786",
        "label": "Venlafaxine",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "EQUIVALENT_TO",
        "concept_id": "CUSTOM:0008",
        "label": "EQUIVALENT_TO",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "reboxetine",
        "condition_name": "depression",
        "relation": "ASSOCIATED_WITH_SE",
        "outcome": null,
        "side_effects": [
          "poor tolerance"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Norepinephrine reuptake inhibitors",
        "span": "However, these findings could be due to the relatively poor tolerance of reboxetine.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "reboxetine",
        "concept_id": "RXNORM:72594",
        "label": "Reboxetine",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "ASSOCIATED_WITH_SE",
        "concept_id": "CUSTOM:0003",
        "label": "ASSOCIATED_WITH_SE",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [
        {
          "text": "poor tolerance",
          "concept_id": null,
          "label": null,
          "provider": null,
          "match_type": "unmatched",
          "score": 0.0
        }
      ],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "trazodone",
        "condition_name": "major depressive disorder",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Other antidepressants",
        "span": "Trazodone is the oldest medication of the so-called 'other antidepressants' group that is still in wide use. It has been shown to be an effective antidepressant in placebo-controlled research.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "trazodone",
        "concept_id": "RXNORM:10737",
        "label": "Trazodone",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "TREATS",
        "concept_id": "CUSTOM:0001",
        "label": "TREATS",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "nefazodone",
        "condition_name": "major depressive disorder",
        "relation": "EQUIVALENT_TO",
        "outcome": null,
        "side_effects": [
          "hepatotoxicity"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Other antidepressants",
        "span": "Nefazodone's structure is analogous to that of trazodone, though it has different pharmacological properties. Its efficacy and overall tolerability are comparable to those of SSRIs, as indicated by comparative trials. However, its use is associated with rare (but fatal) cases of clinical idiosyncratic hepatotoxicity.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "nefazodone",
        "concept_id": "RXNORM:7242",
        "label": "Nefazodone",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "EQUIVALENT_TO",
        "concept_id": "CUSTOM:0008",
        "label": "EQUIVALENT_TO",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [
        {
          "text": "hepatotoxicity",
          "concept_id": "SNOMED:235869004",
          "label": "Drug-induced hepatitis",
          "provider": "snomed",
          "match_type": "synonym",
          "score": 1.0
        }
      ],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "bupropion",
        "condition_name": "major depressive disorder",
        "relation": "EQUIVALENT_TO",
        "outcome": "efficacy",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Other antidepressants",
        "span": "However, for individuals with low to moderate levels of anxiety, the efficacy of bupropion in treating MDD is comparable to that of SSRIs.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": "low to moderate levels of anxiety",
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "bupropion",
        "concept_id": "RXNORM:42347",
        "label": "Bupropion",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "EQUIVALENT_TO",
        "concept_id": "CUSTOM:0008",
        "label": "EQUIVALENT_TO",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": {
        "text": "efficacy",
        "concept_id": "SNOMED:246453008",
        "label": "Treatment efficacy",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "imipramine",
        "condition_name": "major depressive disorder",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [
          "cardiovascular toxicity",
          "anticholinergic side effects"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Perspectives",
        "span": "Imipramine, a tricyclic antidepressant, demonstrated efficacy in patients with more severe symptoms of major depressive disorder. However, it is associated with cardiovascular toxicity and anticholinergic side effects.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "imipramine",
        "concept_id": "RXNORM:3247",
        "label": "Imipramine",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "EFFECTIVE_IN_SUBGROUP",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [
        {
          "text": "cardiovascular toxicity",
          "concept_id": "SNOMED:473010000",
          "label": "Hypotension secondary to drug",
          "provider": "snomed",
          "match_type": "synonym",
          "score": 1.0
        },
        {
          "text": "anticholinergic side effects",
          "concept_id": "SNOMED:281789004",
          "label": "Antibiotic side effects",
          "provider": "snomed",
          "match_type": "synonym",
          "score": 1.0
        }
      ],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "desipramine",
        "condition_name": "major depressive disorder",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [
          "cardiovascular toxicity",
          "anticholinergic side effects"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Perspectives",
        "span": "Desipramine, another tricyclic antidepressant, is effective in patients with more severe symptoms of major depressive disorder but carries risks of cardiovascular toxicity and anticholinergic side effects.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "desipramine",
        "concept_id": "RXNORM:3616",
        "label": "Desipramine",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "EFFECTIVE_IN_SUBGROUP",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [
        {
          "text": "cardiovascular toxicity",
          "concept_id": "SNOMED:473010000",
          "label": "Hypotension secondary to drug",
          "provider": "snomed",
          "match_type": "synonym",
          "score": 1.0
        },
        {
          "text": "anticholinergic side effects",
          "concept_id": "SNOMED:281789004",
          "label": "Antibiotic side effects",
          "provider": "snomed",
          "match_type": "synonym",
          "score": 1.0
        }
      ],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "nortriptyline",
        "condition_name": "major depressive disorder",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [
          "cardiovascular toxicity",
          "anticholinergic side effects"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Perspectives",
        "span": "Nortriptyline is effective in patients with more severe symptoms of major depressive disorder, though it is associated with cardiovascular toxicity and anticholinergic side effects.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "nortriptyline",
        "concept_id": "RXNORM:7531",
        "label": "Nortriptyline",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "EFFECTIVE_IN_SUBGROUP",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [
        {
          "text": "cardiovascular toxicity",
          "concept_id": "SNOMED:473010000",
          "label": "Hypotension secondary to drug",
          "provider": "snomed",
          "match_type": "synonym",
          "score": 1.0
        },
        {
          "text": "anticholinergic side effects",
          "concept_id": "SNOMED:281789004",
          "label": "Antibiotic side effects",
          "provider": "snomed",
          "match_type": "synonym",
          "score": 1.0
        }
      ],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "amitriptyline",
        "condition_name": "major depressive disorder",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [
          "cardiovascular toxicity",
          "anticholinergic side effects"
        ],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Perspectives",
        "span": "Amitriptyline has shown efficacy in patients with more severe symptoms of major depressive disorder, but it is linked to cardiovascular toxicity and anticholinergic side effects.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "amitriptyline",
        "concept_id": "RXNORM:704",
        "label": "Amitriptyline",
        "provider": "rxnorm",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "EFFECTIVE_IN_SUBGROUP",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [
        {
          "text": "cardiovascular toxicity",
          "concept_id": "SNOMED:473010000",
          "label": "Hypotension secondary to drug",
          "provider": "snomed",
          "match_type": "synonym",
          "score": 1.0
        },
        {
          "text": "anticholinergic side effects",
          "concept_id": "SNOMED:281789004",
          "label": "Antibiotic side effects",
          "provider": "snomed",
          "match_type": "synonym",
          "score": 1.0
        }
      ],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "psychotherapy",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "PSYCHOTHERAPY",
        "span": "Psychotherapy for patients with depression strengthens the therapeutic alliance and enables the patient to monitor their mood, improve their functioning, understand their symptoms better, and master the practical tools they need to cope with stressful events.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "psychotherapy",
        "concept_id": "SNOMED:76168009",
        "label": "Psychotherapy",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "TREATS",
        "concept_id": "CUSTOM:0001",
        "label": "TREATS",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "cognitive-behavioral therapy",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Overview of psychotherapy in depression",
        "span": "Depression-focused psychotherapy is typically considered the initial treatment method for mild to moderate MDD. Based on significant clinical evidence, two specific psychotherapeutic methods are recommended: Cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT).",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "cognitive-behavioral therapy",
        "concept_id": "SNOMED:40803007",
        "label": "Cognitive behavioral therapy",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "FIRST_LINE_FOR",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "interpersonal therapy",
        "condition_name": "major depressive disorder",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Overview of psychotherapy in depression",
        "span": "Depression-focused psychotherapy is typically considered the initial treatment method for mild to moderate MDD. Based on significant clinical evidence, two specific psychotherapeutic methods are recommended: Cognitive-behavioral therapy (CBT) and interpersonal therapy (IPT).",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "interpersonal therapy",
        "concept_id": "SNOMED:38678006",
        "label": "Interpersonal therapy",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "FIRST_LINE_FOR",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "mindfulness-based cognitive therapy",
        "condition_name": "major depressive disorder",
        "relation": "MAINTENANCE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Overview of psychotherapy in depression",
        "span": "After remission, CBT, PEI, and mindfulness-based cognitive therapy (MBCT) are proposed to maintain and prevent depression.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "mindfulness-based cognitive therapy",
        "concept_id": "SNOMED:718072006",
        "label": "Mindfulness-based cognitive therapy",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "MAINTENANCE_FOR",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "mindfulness-based cognitive therapy",
        "condition_name": "major depressive disorder",
        "relation": "PREVENTS_RELAPSE_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Overview of psychotherapy in depression",
        "span": "After remission, CBT, PEI, and mindfulness-based cognitive therapy (MBCT) are proposed to maintain and prevent depression.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "mindfulness-based cognitive therapy",
        "concept_id": "SNOMED:718072006",
        "label": "Mindfulness-based cognitive therapy",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "PREVENTS_RELAPSE_IN",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "Cognitive Behavioral Analysis System of Psychotherapy",
        "condition_name": "chronic depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Overview of psychotherapy in depression",
        "span": "The European Psychiatric Association recommends using the Cognitive Behavioral Analysis System of Psychotherapy (CBASP) for treating chronic depression and utilizing specific approaches suited to each patient's preferences.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "Cognitive Behavioral Analysis System of Psychotherapy",
        "concept_id": "CUSTOM:PSY003",
        "label": "Cognitive Behavioral Analysis System of Psychotherapy",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "chronic depression",
        "concept_id": "SNOMED:191616004",
        "label": "Chronic depression",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "TREATS",
        "concept_id": "CUSTOM:0001",
        "label": "TREATS",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "acceptance and commitment therapy",
        "condition_name": "major depressive disorder",
        "relation": "PREVENTS_RELAPSE_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Structured psychotherapies",
        "span": "Acceptance and commitment therapy is another form of CBT. This type of therapy, which is based on functional contextualism, can help patients accept and adjusting to persistent problems. It appears to be effective in reducing depressive symptoms and preventing relapses.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "acceptance and commitment therapy",
        "concept_id": "SNOMED:718073001",
        "label": "Acceptance and commitment therapy",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "major depressive disorder",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "PREVENTS_RELAPSE_IN",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "psycho-education",
        "condition_name": "depression",
        "relation": "IMPROVES",
        "outcome": "clinical course, treatment adherence, psychosocial functioning",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Other psycho-interventions",
        "span": "Many studies have highlighted the role of psycho-education in improving the clinical course, treatment adherence, and psychosocial functioning in patients with depression.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "psycho-education",
        "concept_id": "SNOMED:76168009",
        "label": "Psychotherapy",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "IMPROVES",
        "concept_id": "CUSTOM:0002",
        "label": "IMPROVES",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": {
        "text": "clinical course, treatment adherence, psychosocial functioning",
        "concept_id": "SNOMED:271623007",
        "label": "Quality of life",
        "provider": "snomed",
        "match_type": "fuzzy",
        "score": 0.967741935483871
      },
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "ECT",
        "condition_name": "resistant depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SOMATIC TREATMENTS",
        "span": "ECT is the most well-known treatment for resistant depression, and solid evidence supports its effectiveness and safety.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "ECT",
        "concept_id": "SNOMED:228557008",
        "label": "Electroconvulsive therapy",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "resistant depression",
        "concept_id": "SNOMED:36474008",
        "label": "Treatment-resistant depression",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "TREATS",
        "concept_id": "CUSTOM:0001",
        "label": "TREATS",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "repetitive transcranial magnetic stimulation",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SOMATIC TREATMENTS",
        "span": "In recent decades, various innovative techniques have been proposed, such as repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy, with varying efficiency levels.",
        "confidence": 0.7,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "repetitive transcranial magnetic stimulation",
        "concept_id": "SNOMED:427522004",
        "label": "Repetitive transcranial magnetic stimulation",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "TREATS",
        "concept_id": "CUSTOM:0001",
        "label": "TREATS",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "transcranial direct current stimulation",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SOMATIC TREATMENTS",
        "span": "In recent decades, various innovative techniques have been proposed, such as repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy, with varying efficiency levels.",
        "confidence": 0.7,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "transcranial direct current stimulation",
        "concept_id": "SNOMED:448077001",
        "label": "Transcranial direct current stimulation",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "TREATS",
        "concept_id": "CUSTOM:0001",
        "label": "TREATS",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "vagus nerve stimulation",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SOMATIC TREATMENTS",
        "span": "In recent decades, various innovative techniques have been proposed, such as repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy, with varying efficiency levels.",
        "confidence": 0.7,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "vagus nerve stimulation",
        "concept_id": "SNOMED:710841008",
        "label": "Vagus nerve stimulation",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "TREATS",
        "concept_id": "CUSTOM:0001",
        "label": "TREATS",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "deep brain stimulation",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SOMATIC TREATMENTS",
        "span": "In recent decades, various innovative techniques have been proposed, such as repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy, with varying efficiency levels.",
        "confidence": 0.7,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "deep brain stimulation",
        "concept_id": "SNOMED:80146002",
        "label": "Deep brain stimulation",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "TREATS",
        "concept_id": "CUSTOM:0001",
        "label": "TREATS",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "magnetic seizure therapy",
        "condition_name": "depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "SOMATIC TREATMENTS",
        "span": "In recent decades, various innovative techniques have been proposed, such as repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), vagus nerve stimulation (VNS), deep brain stimulation (DBS), and magnetic seizure therapy, with varying efficiency levels.",
        "confidence": 0.7,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "magnetic seizure therapy",
        "concept_id": "SNOMED:448601003",
        "label": "Magnetic seizure therapy",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "TREATS",
        "concept_id": "CUSTOM:0001",
        "label": "TREATS",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "ECT",
        "condition_name": "major unipolar depression",
        "relation": "SUPERIOR_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "ECT",
        "span": "ECT is arguably the most effective treatment modality in psychiatry, and its superiority over pharmacotherapy for major unipolar depression is widely supported.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "ECT",
        "concept_id": "SNOMED:228557008",
        "label": "Electroconvulsive therapy",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "major unipolar depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "fuzzy",
        "score": 0.8636363636363636
      },
      "relation": {
        "text": "SUPERIOR_TO",
        "concept_id": "CUSTOM:0006",
        "label": "SUPERIOR_TO",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "ECT",
        "condition_name": "severe and psychotic depression",
        "relation": "FIRST_LINE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "ECT",
        "span": "ECT is typically recommended for patients with severe and psychotic depression, a high risk of suicide, or Parkinson's disease, as well as pregnant patients.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "ECT",
        "concept_id": "SNOMED:228557008",
        "label": "Electroconvulsive therapy",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "severe and psychotic depression",
        "concept_id": "SNOMED:310497006",
        "label": "Severe depression with psychotic features",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "FIRST_LINE_FOR",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "rTMS",
        "condition_name": "depression",
        "relation": "IMPROVES",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "rTMS",
        "span": "Recent literature shows a significant difference between rTMS and fictitious stimulation regarding its improvements in depressive symptoms.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "controlled",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "rTMS",
        "concept_id": "SNOMED:427522004",
        "label": "Repetitive transcranial magnetic stimulation",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "IMPROVES",
        "concept_id": "CUSTOM:0002",
        "label": "IMPROVES",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "rTMS",
        "condition_name": "depression",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "rTMS",
        "span": "Preliminary research has revealed synergistic (e.g., rTMS/quetiapine) and antagonizing (e.g., rTMS/cannabinoid receptor (CB1) antagonist) interactions between neuro-modulation and pharmacotherapy.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "preliminary research",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "rTMS",
        "concept_id": "SNOMED:427522004",
        "label": "Repetitive transcranial magnetic stimulation",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "EFFECTIVE_IN_SUBGROUP",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "rTMS",
        "condition_name": "depression",
        "relation": "SUPERIOR_TO",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "rTMS",
        "span": "Treatments combining rTMS and antidepressants are significantly more effective than placebo conditions, with mild side effects and good acceptability.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "controlled",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "rTMS",
        "concept_id": "SNOMED:427522004",
        "label": "Repetitive transcranial magnetic stimulation",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "SUPERIOR_TO",
        "concept_id": "CUSTOM:0006",
        "label": "SUPERIOR_TO",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "tDCS",
        "condition_name": "unipolar depression",
        "relation": "IMPROVES",
        "outcome": "response and remission rate",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "tDCS",
        "span": "The tDCS technique significantly outperforms the simulator in terms of the rate of response and remission. It can be used as a complementary intervention or as monotherapy to reduce depressive symptoms in unipolar or bipolar depression patients.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "controlled",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "tDCS",
        "concept_id": "SNOMED:448077001",
        "label": "Transcranial direct current stimulation",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "unipolar depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "IMPROVES",
        "concept_id": "CUSTOM:0002",
        "label": "IMPROVES",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": {
        "text": "response and remission rate",
        "concept_id": "SNOMED:405053002",
        "label": "Clinical response",
        "provider": "snomed",
        "match_type": "fuzzy",
        "score": 0.9818181818181818
      },
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "tDCS",
        "condition_name": "bipolar depression",
        "relation": "IMPROVES",
        "outcome": "response and remission rate",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "tDCS",
        "span": "The tDCS technique significantly outperforms the simulator in terms of the rate of response and remission. It can be used as a complementary intervention or as monotherapy to reduce depressive symptoms in unipolar or bipolar depression patients.",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "controlled",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "tDCS",
        "concept_id": "SNOMED:448077001",
        "label": "Transcranial direct current stimulation",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "bipolar depression",
        "concept_id": "SNOMED:75532002",
        "label": "Bipolar depression",
        "provider": "snomed",
        "match_type": "exact",
        "score": 1.0
      },
      "relation": {
        "text": "IMPROVES",
        "concept_id": "CUSTOM:0002",
        "label": "IMPROVES",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": {
        "text": "response and remission rate",
        "concept_id": "SNOMED:405053002",
        "label": "Clinical response",
        "provider": "snomed",
        "match_type": "fuzzy",
        "score": 0.9818181818181818
      },
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "VNS",
        "condition_name": "resistant depression",
        "relation": "TREATS",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "VNS",
        "span": "VNS is a therapeutic method that has been used for the last sixteen years to treat resistant unilateral or bipolar depression. However, despite several clinical studies attesting to its favorable benefit-risk ratio and its approval by the Food Drug Administration in 2005, it is not used very often.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "clinical studies",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "VNS",
        "concept_id": "SNOMED:710841008",
        "label": "Vagus nerve stimulation",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "resistant depression",
        "concept_id": "SNOMED:36474008",
        "label": "Treatment-resistant depression",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "TREATS",
        "concept_id": "CUSTOM:0001",
        "label": "TREATS",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "VNS",
        "condition_name": "resistant depression",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "VNS",
        "span": "Since the turn of the century, numerous studies have demonstrated the efficacy of VNS in resistant depression.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": "numerous studies",
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "VNS",
        "concept_id": "SNOMED:710841008",
        "label": "Vagus nerve stimulation",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "resistant depression",
        "concept_id": "SNOMED:36474008",
        "label": "Treatment-resistant depression",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "EFFECTIVE_IN_SUBGROUP",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "VNS",
        "condition_name": "resistant depression",
        "relation": "IMPROVES",
        "outcome": "depressive symptoms",
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "VNS",
        "span": "VNS has demonstrated progressively increasing improvements in depressive symptoms, with significant positive outcomes observed after six to 12 mo; these benefits can last for up to two years.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": "6 to 12 months",
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "VNS",
        "concept_id": "SNOMED:710841008",
        "label": "Vagus nerve stimulation",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "resistant depression",
        "concept_id": "SNOMED:36474008",
        "label": "Treatment-resistant depression",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "IMPROVES",
        "concept_id": "CUSTOM:0002",
        "label": "IMPROVES",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": {
        "text": "depressive symptoms",
        "concept_id": "SNOMED:394924000",
        "label": "Depressive symptom",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "DBS of the subgenual cingulate white matter",
        "condition_name": "resistant depression",
        "relation": "IMPROVES",
        "outcome": "clinical response, clinical remission",
        "side_effects": [],
        "effect_size": "60% response, 35% remission",
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "DBS",
        "span": "According to the literature, DBS of the subgenual cingulate white matter (Brodmann area = BA 25) elicited a clinical response in 60% of resistant depression patients after six months and clinical remission in 35% of patients, with benefits maintained for over 12 mo[144].",
        "confidence": 0.9,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": "6 months",
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "DBS of the subgenual cingulate white matter",
        "concept_id": "SNOMED:80146002",
        "label": "Deep brain stimulation",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "resistant depression",
        "concept_id": "SNOMED:36474008",
        "label": "Treatment-resistant depression",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "IMPROVES",
        "concept_id": "CUSTOM:0002",
        "label": "IMPROVES",
        "provider": "custom",
        "match_type": "exact",
        "score": 1.0
      },
      "outcome": {
        "text": "clinical response, clinical remission",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "side_effects": [],
      "effect_size": "60% response, 35% remission",
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "rTMS",
        "condition_name": "depression",
        "relation": "WELL_TOLERATED_IN",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "Luxtherapy (phototherapy)",
        "span": "rTMS is an interesting technique as well, as it offers a well-tolerated profile.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "rTMS",
        "concept_id": "SNOMED:427522004",
        "label": "Repetitive transcranial magnetic stimulation",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "WELL_TOLERATED_IN",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "ECT",
        "condition_name": "depression",
        "relation": "MAINTENANCE_FOR",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "discussion",
        "span": "ECT is the only somatic treatment with confirmed indications for certain forms of depression.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "ECT",
        "concept_id": "SNOMED:228557008",
        "label": "Electroconvulsive therapy",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "depression",
        "concept_id": "SNOMED:35489007",
        "label": "Major depressive disorder",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "MAINTENANCE_FOR",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    },
    {
      "raw_fact": {
        "drug_name": "combinations of medications, psychotherapy, and somatic therapies",
        "condition_name": "resistant forms of depression",
        "relation": "EFFECTIVE_IN_SUBGROUP",
        "outcome": null,
        "side_effects": [],
        "effect_size": null,
        "confidence_interval": null,
        "source_id": "WJCC",
        "section": "discussion",
        "span": "Combinations of medications, psychotherapy, and somatic therapies remain the most effective ways to manage resistant forms of depression.",
        "confidence": 0.8,
        "treatment_line": null,
        "patient_subgroup": null,
        "study_design": null,
        "sample_size": null,
        "duration": null,
        "dose": null,
        "p_value": null
      },
      "drug": {
        "text": "combinations of medications, psychotherapy, and somatic therapies",
        "concept_id": "CUSTOM:COMBO001",
        "label": "Combined treatment approaches",
        "provider": "custom",
        "match_type": "synonym",
        "score": 1.0
      },
      "condition": {
        "text": "resistant forms of depression",
        "concept_id": "SNOMED:36474008",
        "label": "Treatment-resistant depression",
        "provider": "snomed",
        "match_type": "synonym",
        "score": 1.0
      },
      "relation": {
        "text": "EFFECTIVE_IN_SUBGROUP",
        "concept_id": null,
        "label": null,
        "provider": null,
        "match_type": "unmatched",
        "score": 0.0
      },
      "outcome": null,
      "side_effects": [],
      "effect_size": null,
      "confidence_interval": null
    }
  ]
}